Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGFGanna Tolstanova, Zsuzsanna Sandor, Tetyana Khomenko et al.|Journal of Pharmacology and Experimental Therapeutics|2008Cited by 77
Early endothelial damage and increased colonic vascular permeability in the development of experimental ulcerative colitis in rats and miceGanna Tolstanova, Zsuzsanna Sandor, Xiaoming Deng et al.|Laboratory Investigation|2011Cited by 68
Aging Gastropathy—Novel Mechanisms: Hypoxia, Up-regulation of Multifunctional Phosphatase PTEN, and Proapoptotic FactorsAndrzej S. Tarnawski, Sándor Szabó, Rama Pai et al.|Gastroenterology|2007Cited by 52
Mesalamine Restores Angiogenic Balance in Experimental Ulcerative Colitis by Reducing Expression of Endostatin and Angiostatin: Novel Molecular Mechanism for Therapeutic Action of MesalamineXiaoming Deng, Zsuzsanna Sandor, Ganna Tolstanova et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 42
New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative ColitisXiaoming Deng, Zsuzsanna Sandor, Sándor Szabó et al.|Current Pharmaceutical Design|2011Cited by 39